Cargando…
Microvesicles: the functional mediators in sorafenib resistance
Overcoming drug resistance in cancer therapies remains challenging, and the tumor microenvironment plays an important part in it. Microvesicles (MVs) are functional natural carriers of cellular information, participate in intercellular communication, and dynamically regulate the tumor microenvironme...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511799/ https://www.ncbi.nlm.nih.gov/pubmed/36176764 http://dx.doi.org/10.20517/cdr.2021.137 |
_version_ | 1784797717100232704 |
---|---|
author | He, Cong Jaffar Ali, Doulathunnisa Sun, Bo Sun, Bei-Cheng Xiao, Zhong-Dang |
author_facet | He, Cong Jaffar Ali, Doulathunnisa Sun, Bo Sun, Bei-Cheng Xiao, Zhong-Dang |
author_sort | He, Cong |
collection | PubMed |
description | Overcoming drug resistance in cancer therapies remains challenging, and the tumor microenvironment plays an important part in it. Microvesicles (MVs) are functional natural carriers of cellular information, participate in intercellular communication, and dynamically regulate the tumor microenvironment. They contribute to drug resistance by transferring functional molecules between cells. Conversely, due to their specific cell or tissue targeting ability, MVs are considered as carriers for therapeutic molecules to reverse drug resistance. Thus, in this mini-review, we aim to highlight the crucial role of MVs in cell-to-cell communication and therefore their diverse impact mainly on liver cancer progression and treatment. In addition, we summarize the possible mechanisms for sorafenib resistance (one of the main hurdles in hepatocellular carcinoma treatments) and recent advances in using MVs to reverse sorafenib resistance in liver cancer therapies. Identifying the functional role of MVs in cancer therapy might provide a new aspect for developing precise novel therapeutics in the future. |
format | Online Article Text |
id | pubmed-9511799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | OAE Publishing Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95117992022-09-28 Microvesicles: the functional mediators in sorafenib resistance He, Cong Jaffar Ali, Doulathunnisa Sun, Bo Sun, Bei-Cheng Xiao, Zhong-Dang Cancer Drug Resist Review Overcoming drug resistance in cancer therapies remains challenging, and the tumor microenvironment plays an important part in it. Microvesicles (MVs) are functional natural carriers of cellular information, participate in intercellular communication, and dynamically regulate the tumor microenvironment. They contribute to drug resistance by transferring functional molecules between cells. Conversely, due to their specific cell or tissue targeting ability, MVs are considered as carriers for therapeutic molecules to reverse drug resistance. Thus, in this mini-review, we aim to highlight the crucial role of MVs in cell-to-cell communication and therefore their diverse impact mainly on liver cancer progression and treatment. In addition, we summarize the possible mechanisms for sorafenib resistance (one of the main hurdles in hepatocellular carcinoma treatments) and recent advances in using MVs to reverse sorafenib resistance in liver cancer therapies. Identifying the functional role of MVs in cancer therapy might provide a new aspect for developing precise novel therapeutics in the future. OAE Publishing Inc. 2022-06-23 /pmc/articles/PMC9511799/ /pubmed/36176764 http://dx.doi.org/10.20517/cdr.2021.137 Text en © The Author(s) 2022. https://creativecommons.org/licenses/by/4.0/© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review He, Cong Jaffar Ali, Doulathunnisa Sun, Bo Sun, Bei-Cheng Xiao, Zhong-Dang Microvesicles: the functional mediators in sorafenib resistance |
title | Microvesicles: the functional mediators in sorafenib resistance |
title_full | Microvesicles: the functional mediators in sorafenib resistance |
title_fullStr | Microvesicles: the functional mediators in sorafenib resistance |
title_full_unstemmed | Microvesicles: the functional mediators in sorafenib resistance |
title_short | Microvesicles: the functional mediators in sorafenib resistance |
title_sort | microvesicles: the functional mediators in sorafenib resistance |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511799/ https://www.ncbi.nlm.nih.gov/pubmed/36176764 http://dx.doi.org/10.20517/cdr.2021.137 |
work_keys_str_mv | AT hecong microvesiclesthefunctionalmediatorsinsorafenibresistance AT jaffaralidoulathunnisa microvesiclesthefunctionalmediatorsinsorafenibresistance AT sunbo microvesiclesthefunctionalmediatorsinsorafenibresistance AT sunbeicheng microvesiclesthefunctionalmediatorsinsorafenibresistance AT xiaozhongdang microvesiclesthefunctionalmediatorsinsorafenibresistance |